Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

29.58
+0.14000.48%
Post-market: 29.580.00000.00%19:59 EDT
Volume:28.63M
Turnover:846.16M
Market Cap:168.18B
PE:38.93
High:29.74
Open:29.72
Low:29.42
Close:29.44
52wk High:29.88
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.02
T/O Rate:0.51%
Dividend:1.72
Dividend Rate:5.82%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.97
PE(LYR):21.68

Loading ...

From $29 To Over $200: Has Moderna Become Dangerously Overvalued?

Bellwether Stocks Movement
·
1 hour ago

From Algorithms To Oncology: Why IAM Jumped On Day One

Bellwether Stocks Movement
·
Yesterday

RBC Capital Reaffirms Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
4 hours ago

Inflation Shock Sends Wall Street Lower—Why Big Pharma Became The Market’s Refuge

Sector Pulse
·
Yesterday

Pharma Stocks Jump. Eli Lilly, AstraZeneca up over 4%; Novo Nordisk up over 3%; Moderna, J&J, Merck, Pfizer up over 2%

Tiger Newspress
·
Oct 15

Pfizer (PFE) Could Be 60% Below Fair Value On Tukysa Approval And Vaccine Data

Simply Wall St.
·
Oct 15

Pfizer Inc Stock (PFE) Moved Up by 3.14% on Oct 14: Drivers Behind the Movement

TradingKey
·
Oct 15

Pfizer’s Next‑Gen Pneumococcal Shot Enters Key Phase 3 Test, Extending Vaccine Growth Potential

TIPRANKS
·
Oct 15

Movement Alert|Pfizer Intraday Rise 3.05% in Regular Trading, price target increases and recent FDA approval support sentiment

Market Focus
·
Oct 14

Pfizer Posts Phase 3 Data for Lyme Vaccine Candidate LB6V at IDWeek 2026

Reuters
·
Oct 14

Pfizer Showcases Clinical Advancements Across Infectious Diseases at Idweek 2026

THOMSON REUTERS
·
Oct 14

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Oct 14

Enodia Therapeutics: Pfizer Will be Responsible for All Clinical, Manufacturing, Regulatory and Commercial Activities

THOMSON REUTERS
·
Oct 13

Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop SEC61-Targeting Small Molecules

THOMSON REUTERS
·
Oct 13

Enodia Therapeutics : Deal with Pfizer Has Total Potential Value over $500M Including Upfront, Milestones and Royalties

THOMSON REUTERS
·
Oct 13

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)

TIPRANKS
·
Oct 13

Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (OtherCOGZF) and Pfizer (PFE)

TIPRANKS
·
Oct 13

Reddit and Perplexity AI Clash over Law Firm's Role in Data-Scraping Case

Reuters
·
Oct 13

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)

TIPRANKS
·
Oct 13

High-Yield Stocks Are Back, But Beware The Value Traps

Options & Short Sell
·
Oct 12